stars 1 stars 2 stars 3

Our organs, tissues, and vessels are soft. But today's catheters are stiff and straight. For decades, this has restricted access and forced complicated workarounds in endovascular interventions. Until now. Our Transforming Fixation (TFX) technology rewrites the rules. TFX allows catheters to shift from flexible to firm in milliseconds, giving physicians true stability and control while protecting the cardiovascular anatomy — unlocking powerful opportunities to redefine therapies and improve the lives of millions of patients. Less mess. Less stress. With TFX, today’s challenges are history. Jupiter Endovascular is a medical technology startup based in the San Francisco Bay Area, led by a team of successful medical device entrepreneurs. We have big ambitions, with a culture built on innovation, teamwork, and speed.

Jupiter Endovascular Questions

Carl st. Bernard is the CEO of Jupiter Endovascular.

37 people are employed at Jupiter Endovascular.

Jupiter Endovascular is based in Menlo Park, California.

Top Jupiter Endovascular Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Spring 2026 G2 Best Est ROI Mid Market Spring 2026 G2 Easiest Admin Mid Market Spring 2026 G2 Most Implementable Spring 2026 G2 Best Results Mid Market Spring 2026 G2 Lead Capture Mid Market Spring 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users